FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christopher Bever Jr

Research Profile

Disorders

Chemicals & Drugs

Occupations

Robotics

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Vamshi K Nimmagadda; Walter III Royal; James W Russell; Saifi Talat; G David Trisler; Narasimha R Vattikunta; Vakas Ahmad; Christopher Bever Jr; Krish Chandrasekaran; Susan I V Judge; Naveen K Nagalla; Tapas K Makar
Overexpression of SIRT1 Protein in Neurons Protects against Experimental Autoimmune Encephalomyelitis through Activation of Multiple SIRT1 Targets.
James Goolsby; Tapas K Makar; Bernard Pessac; Christopher Bever Jr; Suhayl Dhib-Jalbut; G David Trisler
Hematopoietic progenitors express myelin basic protein and ensheath axons in Shiverer brain.
Cosmin A Tegla; Richard Trippe; Violeta Rus; Anil K Singh; Maria Andrian-Albescu; Philippe Azimzadeh; Christopher Bever Jr; Hegang Chen; Cornelia Cudrici; Ali Khan; Walter III Royal; Horea Rus
Dual role of Response gene to complement-32 in multiple sclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christopher Bever Jr (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vamshi K Nimmagadda; Walter III Royal; James W Russell; Saifi Talat; G David Trisler; Narasimha R Vattikunta; Vakas Ahmad; Christopher Bever Jr; Krish Chandrasekaran; Susan I V Judge; Naveen K Nagalla; Tapas K Makar
Overexpression of SIRT1 Protein in Neurons Protects against Experimental Autoimmune Encephalomyelitis through Activation of Multiple SIRT1 Targets.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(9):4595-607.
2013: James Goolsby; Tapas K Makar; Bernard Pessac; Christopher Bever Jr; Suhayl Dhib-Jalbut; G David Trisler
Hematopoietic progenitors express myelin basic protein and ensheath axons in Shiverer brain.
Journal of neuroimmunology 2013;257(1-2):13-20.
2013: Cosmin A Tegla; Richard Trippe; Violeta Rus; Anil K Singh; Maria Andrian-Albescu; Philippe Azimzadeh; Christopher Bever Jr; Hegang Chen; Cornelia Cudrici; Ali Khan; Walter III Royal; Horea Rus
Dual role of Response gene to complement-32 in multiple sclerosis.
Experimental and molecular pathology 2013;94(1):17-28.
2012: Tapas K Makar; Vamshi K C Nimmagadda; Gopi K Patibandla; G David Trisler; Susan I V Judge; Toby Le; Christopher Bever Jr
Use of engineered bone marrow stem cells to deliver brain derived neurotrophic factor under the control of a tetracycline sensitive response element in experimental allergic encephalomyelitis.
Journal of neuroimmunology 2012;252(1-2):1-15.
2012: James Goolsby; Tapas K Makar; Sarah Rollor; Rosemary A Schuh; David Asanuma; Michael Atamas; Christopher Bever Jr; Paul S Fishman; G David Trisler
Retinal neural progenitors express topographic map markers.
Neurochemistry international 2012;61(6):859-65.
2012: Bernard Pessac; Christopher Bever Jr; Paul S Fishman; Tapas K Makar; Vamshi K Nimmagadda; G David Trisler
Adult hematopoietic progenitors are multipotent in chimeric mice.
Comptes rendus biologies 2012;335(7):454-62.
2012: Vijayshree Yadav; Christopher Bever Jr; Dennis N Bourdette; James D Bowen; Gregory G Burrows; Al J Ferro; Andrew Goldstein; Sharon G Lynch; David Mattson; Halina Offner; Jana Preiningerova; Jack Simon; Arthur A Vandenbark
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
Autoimmune diseases 2012;2012():954739.
2012: L Dipietro; Susan E Fasoli; Christopher Bever Jr; H I Krebs; S T Mernoff; J Stein; B T Volpe; N Hogan
Learning, not adaptation, characterizes stroke motor recovery: evidence from kinematic changes induced by robot-assisted therapy in trained and untrained task in the same workspace.
IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 2012;20(1):48-57.
2011: Susan S Conroy; Laura Dipietro; Margaret A Finley; Lauren M Jones-Lush; Hermano I Krebs; Jill Whitall; George F Wittenberg; Min Zhan; Christopher Bever Jr
Effect of gravity on robot-assisted motor training after chronic stroke: a randomized trial.
Archives of physical medicine and rehabilitation 2011;92(11):1754-61.
2011: Todd H Wagner; George F Wittenberg; Christopher Bever Jr; Dawn M Bravata; Pamela W Duncan; Daniel G Federman; Jodie K Haselkorn; Grant D Huang; Hermano I Krebs; Albert C Lo; Peter Peduzzi; Lorie G Richards; Robert J Ringer; Andrew Siroka; Bruce T Volpe; Peter D Guarino
An economic analysis of robot-assisted therapy for long-term upper-limb impairment after stroke.
Stroke; a journal of cerebral circulation 2011;42(9):2630-2.
2011: Anindo Roy; Hermano I Krebs; Christopher Bever Jr; Larry W Forrester; Richard F Macko; Neville Hogan
Measurement of passive ankle stiffness in subjects with chronic hemiparesis using a novel ankle robot.
Journal of neurophysiology 2011;105(5):2132-49.
2011: Nathan B Fountain; P C Van Ness; R Swain-Eng; S Tonn; Christopher Bever Jr
Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.
Neurology 2011;76(1):94-9.
2011: Tzu-Yun McDowell; Walter III Royal; Sania Amr; Christopher Bever Jr; William Culpepper; Patricia Langenberg; Douglas D Bradham
Sun exposure, vitamin D intake and progression to disability among veterans with progressive multiple sclerosis.
Neuroepidemiology 2011;37(1):52-7.
2011: Tzu-Yun McDowell; Sania Amr; William Culpepper; Patricia Langenberg; Walter III Royal; Christopher Bever Jr; Douglas D Bradham
Sun exposure, vitamin D and age at disease onset in relapsing multiple sclerosis.
Neuroepidemiology 2011;36(1):39-45.
2010: Eric Cheng; S Tonn; R Swain-Eng; Stewart A Factor; William J Weiner; Christopher Bever Jr
Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.
Neurology 2010;75(22):2021-7.
2010: Christopher Bever Jr; Gary M Franklin; Joel M Kaufman; Gregory J Esper
Role of professionalism in improving the patient-centeredness, timeliness, and equity of neurological care.
Archives of neurology 2010;67(11):1386-90.
2010: Troy Desai; Christopher Bever Jr
Practice issues in neurology: point of care online resources.
Continuum (Minneapolis, Minn.) 2010;16(5 Multiple Sclerosis):238-42.
2010: Eric M Cheng; Carolyn J Crandall; Christopher Bever Jr; Barbara Giesser; Jodie K Haselkorn; Ron D Hays; Paul Shekelle; Barbara G Vickrey
Quality indicators for multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(8):970-80.
2010: Albert C Lo; Peter D Guarino; Lorie G Richards; Jodie K Haselkorn; George F Wittenberg; Daniel G Federman; Robert J Ringer; Todd H Wagner; Hermano I Krebs; Bruce T Volpe; Christopher Bever Jr; Dawn M Bravata; Pamela W Duncan; Barbara H Corn; Alysia D Maffucci; Stephen E Nadeau; Susan S Conroy; Janet M Powell; Grant D Huang; Peter Peduzzi
Robot-assisted therapy for long-term upper-limb impairment after stroke.
The New England journal of medicine 2010;362(19):1772-83.
2010: Tzu-Yun McDowell; Sania Amr; Patricia Langenberg; Walter III Royal; Christopher Bever Jr; William Culpepper; Douglas D Bradham
Time of birth, residential solar radiation and age at onset of multiple sclerosis.
Neuroepidemiology 2010;34(4):238-44.
2009: Albert C Lo; Peter Guarino; Hermano I Krebs; Bruce T Volpe; Christopher Bever Jr; Pamela W Duncan; Robert J Ringer; Todd H Wagner; Lorie G Richards; Dawn M Bravata; Jodie K Haselkorn; George F Wittenberg; Daniel G Federman; Barbara H Corn; Alysia D Maffucci; Peter Peduzzi
Multicenter randomized trial of robot-assisted rehabilitation for chronic stroke: methods and entry characteristics for VA ROBOTICS.
Neurorehabilitation and neural repair 2009;23(8):775-83.
2009: Christopher Bever Jr; Susan I V Judge
Sustained-release fampridine for multiple sclerosis.
Expert opinion on investigational drugs 2009;18(7):1013-24.
2009: Tapas K Makar; Christopher Bever Jr; Ishwar S Singh; Walter III Royal; Surasri Nandan Sahu; Tushar P Sura; Shireen Sultana; Karna T Sura; Niraj Patel; Suhayl Dhib-Jalbut; G David Trisler
Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle.
Journal of neuroimmunology 2009;210(1-2):40-51.
2009: Margaret A Finley; Laura Dipietro; Jill Ohlhoff; Jill Whitall; Hermano I Krebs; Christopher Bever Jr
The effect of repeated measurements using an upper extremity robot on healthy adults.
Journal of applied biomechanics 2009;25(2):103-10.
2009: Christopher Bever Jr
10 questions about 4-aminopyridine and the treatment of multiple sclerosis.
The neurologist 2009;15(3):161-2.
2008: Tapas K Makar; G David Trisler; Karna T Sura; Shireen Sultana; Niraj Patel; Christopher Bever Jr
Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis.
Journal of the neurological sciences 2008;270(1-2):70-6.
2008: Tapas K Makar; G David Trisler; Christopher Bever Jr; James E Goolsby; Karna T Sura; Shailesh Balasubramanian; Shireen Sultana; Niraj Patel; David Ford; Ishwar S Singh; Aditi Gupta; Reuben M Valenzuela; Suhayl Dhib-Jalbut
Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitis.
Journal of neuroimmunology 2008;196(1-2):67-81.
2008: Christopher Bever Jr; R G Holloway; D J Iverson; R M Dubinsky; R M Richardson; J K Sheffield; D Z Wang; G M Franklin; J M Miyasaki; S T Tonn; J C Stevens
Invited article: Neurology and quality improvement: an introduction.
Neurology 2008;70(18):1636-40.
2008: Robert L Kane; Christopher Bever Jr; Mary Ehrmantraut; Alan Forte; William Culpepper; Mitchell T Wallin
Teleneurology in patients with multiple sclerosis: EDSS ratings derived remotely and from hands-on examination.
Journal of telemedicine and telecare 2008;14(4):190-4.
2007: Susan I V Judge; Paul J Smith; Peggy E Stewart; Christopher Bever Jr
Potassium channel blockers and openers as CNS neurologic therapeutic agents.
Recent patents on CNS drug discovery 2007;2(3):200-28.
2007: Laura Dipietro; Hermano I Krebs; Susan E Fasoli; Bruce T Volpe; Joel Stein; Christopher Bever Jr; Neville Hogan
Changing motor synergies in chronic stroke.
Journal of neurophysiology 2007;98(2):757-68.
2007: J J Halperin; Eugene D Shapiro; E Logigian; Anita L Belman; L Dotevall; Gary P Wormser; Lauren B Krupp; G Gronseth; Christopher Bever Jr
Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurology 2007;69(1):91-102.
2006: Susan I V Judge; Christopher Bever Jr
Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment.
Pharmacology & therapeutics 2006;111(1):224-59.
2006: Susan I V Judge; Jennifer M Lee; Christopher Bever Jr; Paul M Hoffman
Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration.
Journal of rehabilitation research and development 2006;43(1):111-22.
2005: Leah R MacClellan; Douglas D Bradham; Jill Whitall; Bruce T Volpe; P David Wilson; Jill Ohlhoff; Christine Meister; Neville Hogan; Hermano I Krebs; Christopher Bever Jr
Robotic upper-limb neurorehabilitation in chronic stroke patients.
Journal of rehabilitation research and development 2005;42(6):717-22.
2005: Margaret A Finley; Susan E Fasoli; Laura Dipietro; Jill Ohlhoff; Leah R MacClellan; Christine Meister; Jill Whitall; Richard F Macko; Christopher Bever Jr; Hermano I Krebs; Neville Hogan
Short-duration robotic therapy in stroke patients with severe upper-limb motor impairment.
Journal of rehabilitation research and development 2005;42(5):683-92.
2005: Jerome J Graber; Min Zhan; David Ford; F Kursch; Gordon Francis; Christopher Bever Jr; Hillel Panitch; Peter A Calabresi; Suhayl Dhib-Jalbut
Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis.
Journal of neuroimmunology 2005;161(1-2):169-76.
2005: Magnhild Sandberg-Wollheim; Christopher Bever Jr; J Carter; M Färkkilä; B Hurwitz; Y Lapierre; Peter Chang; G S Francis
Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis. The EVIDENCE study.
Journal of neurology 2005;252(1):8-13.
2003: James Goolsby; Marie C Marty; Dafna Heletz; Joshua Chiappelli; Gerti Tashko; Deborah Yarnell; Paul S Fishman; Suhayl Dhib-Jalbut; Christopher Bever Jr; Bernard Pessac; G David Trisler
Hematopoietic progenitors express neural genes.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(25):14926-31.
2003: Gavin Giovannoni; Christopher Bever Jr
Patients with clinically isolated syndromes suggestive of MS: does MRI allow earlier diagnosis?
Neurology 2003;60(1):6-7.
2002: Susan I V Judge; Jay Z Yeh; James E Goolsby; Mervyn Monteiro; Christopher Bever Jr
Determinants of 4-aminopyridine sensitivity in a human brain kv1.4 k(+) channel: phenylalanine substitutions in leucine heptad repeat region stabilize channel closed state.
Molecular pharmacology 2002;61(4):913-20.
2001: Qingdi Q Li; Christopher Bever Jr
Comparison of RANTES chemokine induction by Th1 cytokines in human astroglial cell lines.
International journal of molecular medicine 2001;8(1):95-101.
2001: S R Schwid; Christopher Bever Jr
The cost of delaying treatment in multiple sclerosis: what is lost is not regained.
Neurology 2001;56(12):1620.
2001: Qingdi Q Li; David R Burt; Christopher Bever Jr
Glatiramer acetate inhibition of tumor necrosis factor-alpha-induced RANTES expression and release from U-251 MG human astrocytic cells.
Journal of neurochemistry 2001;77(5):1208-17.
2001: Qingdi Q Li; Christopher Bever Jr; David R Burt; Susan I V Judge; G David Trisler
Induction of RANTES chemokine expression in human astrocytic cells is dependent upon activation of NF-kappaB transcription factor.
International journal of molecular medicine 2001;7(5):527-33.
2001: Qingdi Q Li; Christopher Bever Jr
Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cells.
Brain research. Molecular brain research 2001;87(1):48-60.
2001: Qingdi Q Li; Christopher Bever Jr
Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription.
Neurochemical research 2001;26(2):125-33.
2001: Qingdi Q Li; Christopher Bever Jr
Mechanisms underlying the synergistic effect of Th1 cytokines on RANTES chemokine production by human glial cells.
International journal of molecular medicine 2001;7(2):187-95.
1999: Christopher Bever Jr; G A Rosenberg
Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury?
Neurology 1999;53(7):1380-1.
1999: Susan I V Judge; Mervyn Monteiro; Jay Z Yeh; Christopher Bever Jr
Inactivation gating and 4-AP sensitivity in human brain Kv1.4 potassium channel.
Brain research 1999;831(1-2):43-54.
1999: K B Friend; Bernard M Rabin; L Groninger; R H Deluty; Christopher Bever Jr; Lynn M Grattan
Language functions in patients with multiple sclerosis.
The Clinical neuropsychologist 1999;13(1):78-94.
1998: Philip A Mackowiak; Eliot Siegel; Steven Wasserman; E Cameron; Moriel NessAiver; Christopher Bever Jr
Effects of IFN-beta on human cerebral blood flow distribution.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(6):393-7.
1998: Christopher Bever Jr; Lynn M Grattan; J Glenn Morris
Neurologic symptoms following Pfiesteria exposure: case report and literature review.
Maryland medical journal (Baltimore, Md. : 1985) 1998;47(3):120-3.
1998: Q Li; Ron Milo; Hillel Panitch; Christopher Bever Jr
Effect of propranolol and IFN-beta on the induction of MHC class II expression and cytokine production by IFN-gamma IN THP-1 human monocytic cells.
Immunopharmacology and immunotoxicology 1998;20(1):39-61.
1998: Qingdi Q Li; Ron Milo; Hillel Panitch; P Swoveland; Christopher Bever Jr
Glatiramer acetate blocks the activation of THP-1 cells by interferon-gamma.
European journal of pharmacology 1998;342(2-3):303-10.
1998: Qingdi Q Li; Christopher Bever Jr
Modulation of interferon gamma induced increases in cathepsin B in THP-1 cells by adrenergic agonists and antagonists.
Cell biology international 1998;22(1):13-20.
1998: Qingdi Q Li; Christopher Bever Jr
Effect of protein kinase modulators on the regulation of cathepsin B activity in THP-1 human monocytic leukemia cells.
Oncology reports 1998;5(1):227-33.
1997: Q Li; Christopher Bever Jr
Regulation of cathepsin B activity by modulators of arachidonic acid metabolism in human monocytes.
Oncology reports 1997;4(6):1255-60.
1997: Qingdi Q Li; William A Falkler; Christopher Bever Jr
Endotoxin induces increased intracellular cathepsin B activity in THP-1 cells.
Immunopharmacology and immunotoxicology 1997;19(2):215-37.
1997: Qingdi Q Li; Christopher Bever Jr
Interferon-gamma induced increases in intracellular cathepsin B activity in THP-1 cells are dependent on RNA transcription.
Journal of neuroimmunology 1997;74(1-2):77-84.
1996: Christopher Bever Jr; P A Anderson; James L Leslie; Hillel Panitch; Suhayl Dhib-Jalbut; OA Khan; Ron Milo; J Richard Hebel; K L Conway; E Katz; Kenneth P Johnson
Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial.
Neurology 1996;47(6):1457-62.
1996: Qingdi Q Li; Christopher Bever Jr
Gamma interferon induced increases in intracellular cathepsin B activity in PMA primed THP-1 cells are blocked by inhibitors of protein kinase C.
Immunopharmacology and immunotoxicology 1996;18(3):375-96.
1996: OA Khan; Q Xia; Christopher Bever Jr; Kenneth P Johnson; Hillel Panitch; Suhayl Dhib-Jalbut
Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration.
Neurology 1996;46(6):1639-43.
1995: Christopher Bever Jr; Lynn M Grattan; Hillel Panitch; Kenneth P Johnson
The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study.
Multiple sclerosis (Houndmills, Basingstoke, England) 1995;1(3):165-9.
1995: Christopher Bever Jr; D W Garver
Increased cathepsin B activity in multiple sclerosis brain.
Journal of the neurological sciences 1995;131(1):71-3.
1994: Christopher Bever Jr; D Young; P A Anderson; Allan Krumholz; K Conway; James L Leslie; Natalie D. Eddington; K I Plaisance; Hillel Panitch; Suhayl Dhib-Jalbut
The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.
Neurology 1994;44(6):1054-9.
1994: Christopher Bever Jr; Hillel Panitch; Kenneth P Johnson
Increased cathepsin B activity in peripheral blood mononuclear cells of multiple sclerosis patients.
Neurology 1994;44(4):745-8.
1994: Christopher Bever Jr
The current status of studies of aminopyridines in patients with multiple sclerosis.
Annals of neurology 1994;36 Suppl():S118-21.
1993: Hillel Panitch; Christopher Bever Jr
Clinical trials of interferons in multiple sclerosis. What have we learned?
Journal of neuroimmunology 1993;46(1-2):155-64.
1993: Christopher Bever Jr
Collaboration and conflict: Ernest E. Hadley and Harry Stack Sullivan, 1930-1945.
The Journal of the American Academy of Psychoanalysis 1993;21(3):387-404.
1992: Christopher Bever Jr; D E McFarlin; H B Levy
A comparison of interferon responses to poly ICLC in males and females.
Journal of interferon research 1992;Spec No():85-90.
1991: Christopher Bever Jr; R Asofsky
Augmented IgG anti-acetylcholine receptor response following chronic penicillamine administration.
Journal of neuroimmunology 1991;35(1-3):131-7.
1991: Christopher Bever Jr; Hillel Panitch; H B Levy; D E McFarlin; Kenneth P Johnson
Gamma-interferon induction in patients with chronic progressive MS.
Neurology 1991;41(7):1124-7.
1991: Christopher Bever Jr; S Jacobson; E S Mingioli; Henry McFarland; D E McFarlin; H B Levy
Changes in leukocyte recirculation, NK cell activity, and HLA-DR expression in peripheral blood mononuclear cells of MS patients treated with Poly ICLC.
International journal of immunopharmacology 1991;13(5):613-8.
1990: Christopher Bever Jr; P Swoveland
Astrocytosis and cathepsin D activity in experimental measles encephalomyelitis.
Neurochemical research 1990;15(7):667-71.
1990: Christopher Bever Jr; James L Leslie; D L Camenga; Hillel Panitch; Kenneth P Johnson
Preliminary trial of 3,4-diaminopyridine in patients with multiple sclerosis.
Annals of neurology 1990;27(4):421-7.
1989: James L Leslie; Christopher Bever Jr
Analysis of 3,4-diaminopyridine in human serum by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.
Journal of chromatography 1989;496(1):214-22.
1989: Christopher Bever Jr; K D Morgan; J N Whitaker
Cathepsin D activity in human peripheral blood mononuclear leukocytes.
Inflammation 1989;13(3):309-16.
1989: Christopher Bever Jr; D S Snyder; R O Endres; K D Morgan; A Postlethwaite; J N Whitaker
Activation of astrocytic lysosomal proteinases by factors released by mononuclear leukocytes.
Neurochemical research 1989;14(1):37-41.
1988: Christopher Bever Jr; Henry McFarland; D E McFarlin; H B Levy
The kinetics of interferon induction by poly ICLC in humans.
Journal of interferon research 1988;8(4):419-25.
1988: Christopher Bever Jr; Henry McFarland; H B Levy; D E McFarlin
Cortisol induction by poly ICLC: implications for clinical trials of interferon.
Annals of neurology 1988;23(2):196-9.
1986: Christopher Bever Jr; A M Salazar; E Neely; B E Ferraraccio; J W Rose; Henry McFarland; H B Levy; D E McFarlin
Preliminary trial of poly ICLC in chronic progressive multiple sclerosis.
Neurology 1986;36(4):494-8.
1985: W A Hess; Christopher Bever Jr; D E McFarlin
Liver enzyme abnormalities after poly ICLC infusions.
Cancer treatment reports 1985;69(11):1342.
1985: D E McFarlin; Christopher Bever Jr; A M Salazar; H B Levy
A preliminary trial of poly(I,C)-LC in multiple sclerosis.
Journal of biological response modifiers 1985;4(5):544-8.
1985: Christopher Bever Jr; J N Whitaker
Proteinases in inflammatory demyelinating disease.
Springer seminars in immunopathology 1985;8(3):235-50.
1985: Christopher Bever Jr; D E McFarlin; H B Levy
A comparison of interferon responses to poly ICLC in males and females.
Journal of interferon research 1985;5(3):423-8.
1984: R Eldridge; C P Anayiotos; S Schlesinger; D Cowen; Christopher Bever Jr; N Patronas; Henry McFarland
Hereditary adult-onset leukodystrophy simulating chronic progressive multiple sclerosis.
The New England journal of medicine 1984;311(15):948-53.
1984: Christopher Bever Jr; K L Dretchen; G J Blake; H W Chang; A S Penn; R Asofsky
Augmented anti-acetylcholine receptor response following long-term penicillamine administration.
Annals of neurology 1984;16(1):9-13.
1983: Christopher Bever Jr; A V Aquino; A S Penn; R E Lovelace; L P Rowland
Prognosis of ocular myasthenia.
Annals of neurology 1983;14(5):516-9.
1983: J R Miller; A M Burke; Christopher Bever Jr
Occurrence of oligoclonal bands in multiple sclerosis and other CNS diseases.
Annals of neurology 1983;13(1):53-8.
1982: Christopher Bever Jr; H W Chang; A S Penn; Israeli A Jaffe; E Bock
Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor.
Neurology 1982;32(10):1077-82.
1979: M Reynard; C Wertenbaker; M Behrens; Ronald P Lesser; H Eggers; J Ilson; J Mitchell; Christopher Bever Jr
"Ping-pong gaze" amplified.
Neurology 1979;29(5):757-8.